Browsing Tag
Pelareorep
3 posts
Is pelareorep gaining traction? Oncolytics Biotech’s updated GOBLET data draws investor focus to third-line anal cancer
Find out why Oncolytics Biotech’s updated GOBLET cohort 4 data is drawing investor attention to pelareorep’s role in third-line anal cancer.
January 15, 2026
Breakthrough trial: Oncolytics Biotech’s pelareorep combo doubles response rate in advanced anal cancer
Find out how Oncolytics Biotech’s breakthrough trial doubled response rates in advanced anal cancer and set up a 2026 FDA path.
October 28, 2025
Oncolytics Biotech signs $20m share purchase deal with Alumni Capital to advance pelareorep development
Oncolytics Biotech inks $20M share deal with Alumni Capital to support pelareorep trials in breast and pancreatic cancer. Read how the biotech firm is advancing.
April 13, 2025